Tough market conditions fail to deter discussions about R&D investments, new technologies: GlobalData Read more
Novel pipeline therapies to drive diabetic neuropathic pain market across 7MM to $3 bn in 2031: GlobalData Read more
Moderna’s non-vaccine mRNA therapeutic can generate $278 million in 2028 if approved: GlobalData Read more
AI, Big Data will be the most impactful emerging technologies for pharma in 2023: GlobalData Read more
Inflation, drug pricing and reimbursement constraints will have the biggest negative impact on biopharma industry in 2023: GlobalData Read more